Cours OHR Pharmaceutical Inc Nasdaq
Actions
US67778H3093
Recherche biotechnologique et médicale
CA 2023 * | - | CA 2024 * | - | Capitalisation | 1,46 M 1,33 M |
---|---|---|---|---|---|
Résultat net 2023 * | -12 M -10,88 M | Résultat net 2024 * | - | VE / CA 2023 * | - |
Trésorerie nette 2023 * | - 0 | Trésorerie nette 2024 * | - 0 | VE / CA 2024 * | - |
PER 2023 * |
-0,05
x | PER 2024 * |
-
| Employés | - |
Rendement 2023 * |
-
| Rendement 2024 * |
-
| Flottant | 86,62% |
Dernier transcript sur OHR Pharmaceutical Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 10/01/22 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 01/11/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 12/07/19 |
Eric Richman
BRD | Director/Board Member | 63 | 12/07/19 |
Gerald McDougall
BRD | Director/Board Member | 57 | 11/05/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
+23,37% | 47,02 Md | |
+48,83% | 41,86 Md | |
-0,94% | 41,76 Md | |
-5,86% | 28,8 Md | |
+11,29% | 26,05 Md | |
-20,92% | 19,15 Md | |
+3,20% | 12,55 Md | |
-2,67% | 11,82 Md | |
+30,23% | 12,34 Md |